Clinical trial
Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial…
NCT00204607 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204607 |
|---|---|
| Title | Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients |
| Official title | Induction of Specific Immune Responses Against Melanoma-Associated Antigens in Vivo by Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Melanoma |
| Intervention type | Biological, Drug |
| Interventions | mRNA, GM-CSF s.c. |
| Enrollment | 20 |
| Start date | Jul 1, 2004 |
| Completion | Jan 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 19, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: